Jaguar Health announces 1-for-15 reverse stock split effective Sept 17, 2026

Jaguar Health, Inc.

1-for-15 reverse split effective 12:01 am ET Sept 17, 2026; trading begins split-adjusted on Nasdaq under JAGX.
Split approved by stockholders at April 20, 2026 special meeting; board set exact ratio at 1-for-15.
Purpose is to support compliance with Nasdaq listing standards (minimum bid price requirement).
New CUSIP 47010C854; no fractional shares—cash paid in lieu; Equiniti Trust Company acts as exchange agent.
Outstanding options, warrants, and equity plan reserves adjusted proportionately; par value unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.